The collaboration combines Shaare Zedek's real-world data and clinical expertise with Imagene AI's Oncology Intelligence Suite to advance biomarker discovery and accelerate precision cancer care. TEL ...
Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC) ...
Setting a New Standard for Facial Rejuvenation and Aesthetic Expertise NEW YORK CITY, NY / ACCESS Newswire / October 29, 2025 / Dr. Mansher Singh, a Manhattan-based facial plastic surgeon, is proud to ...
Aspira Executes New, Scalable Laboratory Services Agreement in One of the Largest Markets in the US AUSTIN, TX AND WASHINGTON, DC / ACCESS Newswire / October 29, 2025 / Aspira Women's Health Inc., ...
The Compassion Center and its Coalition for Patient Rights (CPR) tap Las Vegas mainstay Lex LasVegas to host a family-friendly day of music, advocacy, and community well-being on Saturday, November 15 ...
Lundbeck teams up with OpenAI to roll out ChatGPT Enterprise across its business, reinforcing its brain-health mission with ...
Affordable, clinician-reviewed assessments help SBCC reach accommodation decisions sooner and keep students on track during critical academic periods. GRAND RAPIDS, MI AND SANTA BARBARA, CA / ACCESS ...
Lincolnshire’s hospitalsAI-powered automation has resulted in reduced CT scan time from 15 minutes to 8/9 minutes140% increase on non-obstetric ultrasound scans in 2025-2026, compared to pre-COVID-19 ...
Enzene, a leading global continuously innovative development and manufacturing organization (CIDMO), today welcomed the news that its EnzeneX™ 2.0 platform, featuring fully-connected continuous ...
UCB will showcase 18 abstracts, including an oral presentation, demonstrating continued commitment to advancing targeted treatments for generalized Myasthenia Gravis (gMG).Presentations include new ...
HAMBURG, DE / ACCESS Newswire / October 29, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) will announce its interim ...
SA02, demonstrated earlier resolution in patients with Staphylococcus aureus bacteremia (SAB) in a Phase IIa trial, reinforcing the growing clinical promise of bacteriophage-based treatments. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback